A comparative analysis of first-line therapies, TC and CAP, for patients with LA-R/M SGC yielded no significant distinctions in terms of overall response rate, progression-free survival, and overall survival. Neoplastic alterations of the vermiform appendix, generally considered infrequent, might be...